Serbia Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Startup Hiring: How to Hire the Best People Attract and retain the best people. 7 lectures from top founders and CEO's about how to hire for your startup! Sign up for $19. From our sponsors

Serbia Pharmaceuticals and Healthcare Report Q4 2013 Oct 23rd 2013, 00:00 Price: $ 1295   BMI View: Despite per capita expenditure on drugs increasing considerably towards the end of the last decade, Serbia's pharmaceutical market as a whole is underdeveloped in regional terms, having suffered as a result of political and economic instability.. As the country continues its economic convergence with developed Europe, drug consumption is also expected to rise. However, financial inefficiencies within the health insurance system mean that the National Health Insurance Institution (RZZO) is unable to always meet its obligations on time, with frequent changes to coverage and pharmaceutical pricing. Headline Expenditure Projections ? Pharmaceuticals: RSD81.38bn (US$0.93bn) in 2012 to RSD90.97bn (US$1.10bn) in 2013; +11.8% in local currency terms and +18.9% in US dollar terms. Forecast ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/286354.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions